Evaluation and Transplantation of a SARS-CoV-2 Seropositive Kidney Candidate

The COVID-19 pandemic affected transplant center activity in areas with high number of cases such as New York City and prompted reevaluation of patients awaiting organ transplant diagnosed with SARS-CoV-2 infection. To resume safe transplantation at our center, we found it necessary to (1) identify...

Full description

Saved in:
Bibliographic Details
Main Authors: Maya C. Graves, Sapna A. Mehta, Bonnie E. Lonze, Nicole M. Ali
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Case Reports in Nephrology
Online Access:http://dx.doi.org/10.1155/2021/6613023
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564914608144384
author Maya C. Graves
Sapna A. Mehta
Bonnie E. Lonze
Nicole M. Ali
author_facet Maya C. Graves
Sapna A. Mehta
Bonnie E. Lonze
Nicole M. Ali
author_sort Maya C. Graves
collection DOAJ
description The COVID-19 pandemic affected transplant center activity in areas with high number of cases such as New York City and prompted reevaluation of patients awaiting organ transplant diagnosed with SARS-CoV-2 infection. To resume safe transplantation at our center, we found it necessary to (1) identify transplant candidates with possible exposure to or history of COVID-19 infection, (2) outline a clinical and laboratory assessment to determine adequate clinical recovery from COVID-19 for transplantation, and (3) determine whether the possibility of perioperative COVID-19 transmission from the patient to staff would pose unacceptable risk. Here, we describe our center’s approach to proceeding with transplantation in a SARS-CoV-2 seropositive living donor kidney transplant recipient and describe early posttransplant outcomes.
format Article
id doaj-art-ca16626f95e1407eb5fda4f51d983b44
institution Kabale University
issn 2090-6641
2090-665X
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Case Reports in Nephrology
spelling doaj-art-ca16626f95e1407eb5fda4f51d983b442025-02-03T01:09:56ZengWileyCase Reports in Nephrology2090-66412090-665X2021-01-01202110.1155/2021/66130236613023Evaluation and Transplantation of a SARS-CoV-2 Seropositive Kidney CandidateMaya C. Graves0Sapna A. Mehta1Bonnie E. Lonze2Nicole M. Ali3New York University Grossman School of Medicine, New York, NY, USANew York University Grossman School of Medicine, New York, NY, USANew York University Grossman School of Medicine, New York, NY, USANew York University Grossman School of Medicine, New York, NY, USAThe COVID-19 pandemic affected transplant center activity in areas with high number of cases such as New York City and prompted reevaluation of patients awaiting organ transplant diagnosed with SARS-CoV-2 infection. To resume safe transplantation at our center, we found it necessary to (1) identify transplant candidates with possible exposure to or history of COVID-19 infection, (2) outline a clinical and laboratory assessment to determine adequate clinical recovery from COVID-19 for transplantation, and (3) determine whether the possibility of perioperative COVID-19 transmission from the patient to staff would pose unacceptable risk. Here, we describe our center’s approach to proceeding with transplantation in a SARS-CoV-2 seropositive living donor kidney transplant recipient and describe early posttransplant outcomes.http://dx.doi.org/10.1155/2021/6613023
spellingShingle Maya C. Graves
Sapna A. Mehta
Bonnie E. Lonze
Nicole M. Ali
Evaluation and Transplantation of a SARS-CoV-2 Seropositive Kidney Candidate
Case Reports in Nephrology
title Evaluation and Transplantation of a SARS-CoV-2 Seropositive Kidney Candidate
title_full Evaluation and Transplantation of a SARS-CoV-2 Seropositive Kidney Candidate
title_fullStr Evaluation and Transplantation of a SARS-CoV-2 Seropositive Kidney Candidate
title_full_unstemmed Evaluation and Transplantation of a SARS-CoV-2 Seropositive Kidney Candidate
title_short Evaluation and Transplantation of a SARS-CoV-2 Seropositive Kidney Candidate
title_sort evaluation and transplantation of a sars cov 2 seropositive kidney candidate
url http://dx.doi.org/10.1155/2021/6613023
work_keys_str_mv AT mayacgraves evaluationandtransplantationofasarscov2seropositivekidneycandidate
AT sapnaamehta evaluationandtransplantationofasarscov2seropositivekidneycandidate
AT bonnieelonze evaluationandtransplantationofasarscov2seropositivekidneycandidate
AT nicolemali evaluationandtransplantationofasarscov2seropositivekidneycandidate